NCT05419856View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Knee Osteoarthritis
Interventions
DRUG

4P-004

single intraarticular administration in the knee joint

DRUG

Placebo

single intraarticular administration in the knee joint

Trial Locations (3)

1200

UCL-St Luc, Brussels

3000

UZ Leuven, Leuven

9000

AZMaria Middelares, Ghent

Sponsors

Lead Sponsor

4Moving Biotech
All Listed Sponsors
lead

4Moving Biotech

INDUSTRY